314 related articles for article (PubMed ID: 22819647)
1. A new water-soluble Cu(II) chelator that retrieves Cu from Cu(amyloid-β) species, stops associated ROS production and prevents Cu(II)-induced Aβ aggregation.
Noël S; Perez F; Pedersen JT; Alies B; Ladeira S; Sayen S; Guillon E; Gras E; Hureau C
J Inorg Biochem; 2012 Dec; 117():322-5. PubMed ID: 22819647
[TBL] [Abstract][Full Text] [Related]
2. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
Drew SC; Barnham KJ
Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy.
Storr T; Merkel M; Song-Zhao GX; Scott LE; Green DE; Bowen ML; Thompson KH; Patrick BO; Schugar HJ; Orvig C
J Am Chem Soc; 2007 Jun; 129(23):7453-63. PubMed ID: 17511455
[TBL] [Abstract][Full Text] [Related]
4. pH-Dependent Cu(II) coordination to amyloid-β peptide: impact of sequence alterations, including the H6R and D7N familial mutations.
Alies B; Eury H; Bijani C; Rechignat L; Faller P; Hureau C
Inorg Chem; 2011 Nov; 50(21):11192-201. PubMed ID: 21980910
[TBL] [Abstract][Full Text] [Related]
5. Two pyridine derivatives as potential Cu(II) and Zn(II) chelators in therapy for Alzheimer's disease.
Lakatos A; Zsigó E; Hollender D; Nagy NV; Fülöp L; Simon D; Bozsó Z; Kiss T
Dalton Trans; 2010 Feb; 39(5):1302-15. PubMed ID: 20104357
[TBL] [Abstract][Full Text] [Related]
6. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
Faller P; Hureau C; La Penna G
Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
[TBL] [Abstract][Full Text] [Related]
7. Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems.
Baruch-Suchodolsky R; Fischer B
Biochemistry; 2009 May; 48(20):4354-70. PubMed ID: 19320465
[TBL] [Abstract][Full Text] [Related]
8. Effect of metal chelators on the aggregation of beta-amyloid peptides in the presence of copper and iron.
Tahmasebinia F; Emadi S
Biometals; 2017 Apr; 30(2):285-293. PubMed ID: 28281098
[TBL] [Abstract][Full Text] [Related]
9. Copper and zinc binding to amyloid-beta: coordination, dynamics, aggregation, reactivity and metal-ion transfer.
Faller P
Chembiochem; 2009 Dec; 10(18):2837-45. PubMed ID: 19877000
[TBL] [Abstract][Full Text] [Related]
10. Identifying, by first-principles simulations, Cu[amyloid-β] species making Fenton-type reactions in Alzheimer's disease.
La Penna G; Hureau C; Andreussi O; Faller P
J Phys Chem B; 2013 Dec; 117(51):16455-67. PubMed ID: 24313818
[TBL] [Abstract][Full Text] [Related]
11. Abeta-mediated ROS production by Cu ions: structural insights, mechanisms and relevance to Alzheimer's disease.
Hureau C; Faller P
Biochimie; 2009 Oct; 91(10):1212-7. PubMed ID: 19332103
[TBL] [Abstract][Full Text] [Related]
12. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
Smith DG; Cappai R; Barnham KJ
Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
[TBL] [Abstract][Full Text] [Related]
13. Histidine-rich branched peptides as Cu(II) and Zn(II) chelators with potential therapeutic application in Alzheimer's disease.
Lakatos A; Gyurcsik B; Nagy NV; Csendes Z; Wéber E; Fülöp L; Kiss T
Dalton Trans; 2012 Feb; 41(6):1713-26. PubMed ID: 22159144
[TBL] [Abstract][Full Text] [Related]
14. Modeling copper binding to the amyloid-β peptide at different pH: toward a molecular mechanism for Cu reduction.
Furlan S; Hureau C; Faller P; La Penna G
J Phys Chem B; 2012 Oct; 116(39):11899-910. PubMed ID: 22974015
[TBL] [Abstract][Full Text] [Related]
15. A Water-Soluble Peptoid Chelator that Can Remove Cu
Behar AE; Sabater L; Baskin M; Hureau C; Maayan G
Angew Chem Int Ed Engl; 2021 Nov; 60(46):24588-24597. PubMed ID: 34510664
[TBL] [Abstract][Full Text] [Related]
16. Pt(II) compounds interplay with Cu(II) and Zn(II) coordination to the amyloid-β peptide has metal specific consequences on deleterious processes associated to Alzheimer's disease.
Collin F; Sasaki I; Eury H; Faller P; Hureau C
Chem Commun (Camb); 2013 Mar; 49(21):2130-2. PubMed ID: 23386213
[TBL] [Abstract][Full Text] [Related]
17. Effects of cyclen and cyclam on zinc(II)- and copper(II)-induced amyloid beta-peptide aggregation and neurotoxicity.
Chen T; Wang X; He Y; Zhang C; Wu Z; Liao K; Wang J; Guo Z
Inorg Chem; 2009 Jul; 48(13):5801-9. PubMed ID: 19496588
[TBL] [Abstract][Full Text] [Related]
18. Nucleoside-5'-phosphorothioate analogues are biocompatible antioxidants dissolving efficiently amyloid beta-metal ion aggregates.
Amir A; Shmuel E; Zagalsky R; Sayer AH; Nadel Y; Fischer B
Dalton Trans; 2012 Jul; 41(28):8539-49. PubMed ID: 22652964
[TBL] [Abstract][Full Text] [Related]
19. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
[TBL] [Abstract][Full Text] [Related]
20. Rationally Designed Cu(I) Ligand to Prevent CuAβ-Generated ROS Production in the Alzheimer's Disease Context.
Rulmont C; Stigliani JL; Hureau C; Esmieu C
Inorg Chem; 2024 Feb; 63(5):2340-2351. PubMed ID: 38243896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
